ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,352.36
0.10%
US Tech 100
18,580.40
0.33%
Dow Jones
38,776.93
-0.06%
Brent Oil
81.345
2.52%
Bitcoin
70,046.63
0.56%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/10/202411:58AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:RYLBFRoyal Bank (PK)
06/10/202411:58AMBusiness WireGodavari Biorefineries Ltd. eröffnet neues Werk für biochemische Spezialprodukte
06/10/202411:57AMBusiness WireEngelhart Commodities Trading Partners vereinbart Übernahme von Trailstone, um sein Engagement für die Energiewende zu stärken
06/10/202411:57AMPR Newswire (US)Detechtion Hires Tim Lozier as VP of Marketing and Corey Scott as VP of Sales to Drive Growth, Create a Winning Go-To-Market Strategy
06/10/202411:56AMAlliance NewsAlliance NewsLONDON MARKET CLOSE: Political turmoil hits euro and banks
06/10/202411:56AMBusiness WirePatent Litigator Tony Nguyen Returns to Fish & Richardson
06/10/202411:56AMPR Newswire (Canada)Devmont's Art Auction Raises Over $650,000 in Support of Multicaf Fundraiser
06/10/202411:55AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
06/10/202411:54AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
06/10/202411:52AMGlobeNewswire Inc.One Liberty Properties Announces 126th Consecutive Quarterly DividendNYSE:OLPOne Liberty Properties Inc
06/10/202411:52AMEdgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:SXTSensient Technologies Corp
06/10/202411:52AMPR Newswire (US)Drug Discovery Informatics Market Size to Grow USD 1 Million by 2030 at a CAGR of 9% | Valuates Reports
06/10/202411:52AMPR Newswire (US)Troutman Pepper to Host Inaugural 'Groundbreakers' Summit on Law Firm Data Innovation
06/10/202411:51AMPR Newswire (Canada)Government of Canada Announces $10 Million to Support Critical Minerals Mining in Northern Ontario
06/10/202411:50AMGlobeNewswire Inc.Solum Global Announces New Protocol to Buy, Sell, Store, and Receive Physical Gold with Digital Currencies
06/10/202411:49AMGlobeNewswire Inc.Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.NASDAQ:SCLXScilex Holding Company
06/10/202411:49AMPR Newswire (Canada)Sécurité des piscines résidentielles - Protéger l'accès à la piscine pour prévenir la noyade
06/10/202411:48AMBusiness WireB2Prime et cTrader élargissent les opportunités de trading grâce à un nouveau partenariat
06/10/202411:48AMPR Newswire (US)PUBLIC HEARINGS SET FOR JUNE 11-13 FOR SENATE MAPS
06/10/202411:48AMPR Newswire (US)Hormone Replacement Therapy Market Size to Grow USD 18280 Million by 2030 at a CAGR of 1.5% | Valuates Reports
06/10/202411:47AMEdgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:SXTSensient Technologies Corp
06/10/202411:47AMGlobeNewswire Inc.Dr. Bernice A. King, CEO of the King Center, Welcomes King and Queen of the Netherlands, Addresses Historical and Systemic Injustices of Slavery
06/10/202411:47AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GMGeneral Motors Company
06/10/202411:46AMGlobeNewswire Inc.Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)BIT:GLESociete Generale SA
06/10/202411:46AMGlobeNewswire Inc.Société Générale : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéEU:GLESociete Generale SA
06/10/202411:46AMGlobeNewswire Inc.Société Générale : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéBIT:GLESociete Generale SA
06/10/202411:46AMGlobeNewswire Inc.Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)EU:GLESociete Generale SA
06/10/202411:46AMGlobeNewswire Inc.Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)TG:SGESociete Generale SA
06/10/202411:46AMGlobeNewswire Inc.Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)BIT:1GLESociete Generale SA
06/10/202411:46AMGlobeNewswire Inc.Société Générale : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéBIT:1GLESociete Generale SA

Your Recent History

USOTC
PSRU
Valiant Eagle (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
ILST
International Star (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
XERI
Xeriant (QB)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
FCEL
FuelCell Energy
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
AGBA
AGBA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved